Your browser is no longer supported. Please, upgrade your browser.
Settings
XBI SPDR S&P Biotech ETF daily Stock Chart
XBI [NYSE]
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.15%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-2.95%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-2.41%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.70 Perf Half Y13.23%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-8.75%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range44.05 - 71.69 Perf YTD-11.60%
Dividend0.32 P/FCF- EPS past 5Y- ROI- 52W High-13.66% Beta-
Dividend %0.52% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low40.52% ATR2.27
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)46.45 Volatility3.27% 3.28%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.90 Prev Close62.10
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume7.01M Price61.90
Recom- SMA20-4.40% SMA50-0.42% SMA2006.30% Volume6,274,282 Change-0.32%
Dec-09-16 04:14PM  Biotech ETFs: A Short-Lived Boon From Biogen at Barrons.com
Dec-08-16 03:00PM  Biotech & Pharma ETFs to Suffer in 2017 Too?
11:27AM  3 Reasons To Shrug Off Trump's Rhetoric On Drug Prices at Barrons.com
10:44AM  Why Biotech is Getting KilledAnd Why It WIll Bounce Back at Barrons.com
Dec-07-16 05:00PM  Bad Day for Biotechs Means It's Time to Buy
04:28PM  Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers
04:06PM  Dow Scores Another Record for Third Consecutive Day; S&P 500 Also Hits New High
02:46PM  Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
02:11PM  President-elect Trumps promise to bring down drug prices sends biotech and pharma ETFs slumping at MarketWatch
01:40PM  Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower
12:40PM  Trumps Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares at 24/7 Wall St.
11:35AM  This indicator says the stock markets celebration has gone too far at MarketWatch
11:31AM  Biotech ETFs: So Much For The Trump Bounce at Barrons.com
11:13AM  Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans
11:03AM  Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
09:14AM  Trump: I'm Going To Bring Down Drug Prices
08:49AM  President-elect Trump's biotech comments sharply lower biotech ETFs at MarketWatch
Dec-05-16 09:01AM  Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November at Motley Fool
Dec-04-16 06:22PM  Billionaire Rob Citrones Monster Q3 Buys: Kellogg, Macys, Activision-Blizzard, More at Insider Monkey
Dec-02-16 09:21AM  3 Biotech Stocks to Buy in December at Motley Fool
08:44AM  Gundlach warns Trump trade is losing steam and stocks have peaked at MarketWatch
08:04AM  Label Expansion May Boost Venclextas Growth Prospects
08:04AM  What Do Analysts Recommend for Gilead Sciences Stock?
Dec-01-16 12:15PM  Nelson: Optimistic about innovation possibly impacting ca...
11:05AM  Valbenazine May Become a Leading Therapy for Tardive Dyskinesia
08:51AM  Five ways to evaluate an Obamacare replacement plan at MarketWatch
08:50AM  What to expect from HHS Secretary nominee and Obamacare opponent Tom Price at MarketWatch
08:06AM  Why AbbVie Wants to Develop Anti-Tau Therapies
Nov-29-16 05:04PM  Next-Generation Hepatitis C Therapy May Be AbbVies Growth Driver
02:00PM  AbbVies Financial Guidance for 2017
Nov-23-16 10:16AM  Analysts say Juno's stock tumbles shouldn't spill over to Bluebird, Kite Pharma shares at MarketWatch
Nov-22-16 10:08AM  How Stocks and Bonds Reacted to Trumps Victory
Nov-17-16 12:18PM  Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios
08:34AM  Leading Indicator, testing key breakout level!
Nov-16-16 05:22PM  Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?
08:15AM  Biotech takes Trump presidency as a green light and end to drug price worries at MarketWatch
Nov-14-16 10:57AM  5 Reasons to Buy 5 Low P/E Biotech ETFs
Nov-13-16 11:20AM  Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
Nov-11-16 05:05PM  November Surprise Rallies Stocks
Nov-10-16 11:26AM  The death of Obamacare will bring new opportunities for investors at MarketWatch
Nov-09-16 10:58AM  Here's Why Keryx Biopharmaceuticals Fell 18% in October at Motley Fool +10.37%
09:48AM  Drug and Biotech Stocks Rise as Price Clampdown Fears Ease Under Trump Presidency (Updated)
Nov-08-16 11:06AM  Investors Have Dumped Health-Care Stocks, Regardless of the Polls at The Wall Street Journal
09:34AM  Which S&P 500 Sectors Do the Best for an Incumbent Democrat?
Nov-07-16 01:22PM  Biotech ETFs Boosted By Biogen at Barrons.com
10:02AM  Healthcare ETFs in the Spotlight as Election Approaches
Nov-04-16 05:40PM  SPY ETF Tests A Key Level As Every S&P Sector Posts A Weekly Loss
06:45AM  'The Sky Is Literally Falling' -- Health Care Investor Sentiment Sinks to End-Time Lows
Nov-02-16 11:04AM  How Is Kanuma Progressing Globally?
08:15AM  Stock market fear factor rises as Clinton-Trump race tightens at MarketWatch
07:02AM  Allergan's stock gains as $10 billion ASR and new dividend offsets profit and sales miss at MarketWatch
Nov-01-16 03:54PM  Eli Lilly's Stock Price Feels the Bern at The Wall Street Journal
12:46PM  Top ETF Stories of October
11:12AM  October ETF Performance Report
Oct-31-16 06:04PM  Analyst Recommendations for BioMarin after Its 3Q16 Earnings
05:58PM  Final Trade: DVA, UA & more
05:39PM  Can Key Level Stop The Bleeding In Health Care Stocks?
05:01PM  Win-win election plays
11:58AM  Obamacare: Will the Next US President Kill It or Cure It?
Oct-27-16 04:19PM  Amgen beats profit expectations and raises its outlook at MarketWatch
Oct-26-16 12:00PM  Charts Suggest 2017 Will Be the Year of Biotech at Investopedia
10:58AM  Biotech Stocks: Did Trump Video Cost Investors $50 Billion? at Barrons.com
Oct-25-16 06:14AM  [$$] The Next Big Moves in Health-Care Stocks at Barrons.com
Oct-20-16 06:45PM  Major ETFs Fall, But Biotech And Pharma Stocks Defy General Malaise
01:57PM  Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
12:00PM  Trending on ETFdb.com: Samsung Electronics Hurt by Galaxy Note 7 Recall Crisis
Oct-17-16 10:10AM  ETFs to Play as Biotech Juggles Election & Earnings
Oct-14-16 03:26PM  Can Biotech Stocks Stay Trendy?
Oct-13-16 04:37PM  Can These Top 5 Biotechs Climb Q3 'Wall Of Worry'? RBC Calls For Rally
Oct-12-16 05:01PM  Biotech ETFs get rocked a 2nd straight day at MarketWatch
Oct-11-16 04:59PM  Biotech Stocks Smacked For Biggest Decline in 3 1/2 Months at The Wall Street Journal
Oct-06-16 03:47PM  Options Insight: How to Trade the SPDR S&P Biotech ETF
03:21PM  Biotech ETFs Punished For Owning Alnylam at Barrons.com
01:00PM  Top 50 ETFs Over Five Years: Health Care Loses Some Ground at Forbes
10:00AM  How To Avoid The Worst Sector ETFs at Forbes
07:47AM  What's behind put spike in biotechs
Oct-01-16 12:01AM  [$$] How to Play the Next Biotech M&A Surge at Barrons.com
Sep-27-16 10:57AM  Expect More Volatility for Healthcare ETFs
Sep-24-16 01:00AM  [$$] Biotech Is Cheaper Than Big Pharma at Barrons.com
Sep-22-16 11:53AM  Gilead Sciences: Another Blow to R&D Strategy at Barrons.com
Sep-21-16 11:23AM  Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
10:05AM  Ionis, GlaxoSmithKline Partner on Abnormal Protein Treatment
Sep-20-16 06:05PM  Biotech ETF At Best Level Since January; Are You Braced For Bumps?
05:04PM  How Ioniss Revenue Trends Are Changing
12:37PM  Charting the S&P 500s bullish-leaning holding pattern ahead of the Fed at MarketWatch
12:28PM  Tuesday links: personal well-being
Sep-17-16 11:46AM  The Week Ahead: Should You Care About The 'Bulls No.1 Lie?' at Forbes
Sep-16-16 10:06AM  A Battered Biotech ETF can Rise Again
Sep-15-16 05:42PM  Biotech bright spots
Sep-14-16 03:12PM  A Good Trader Should Be Able to Adjust to Changing Markets
02:19PM  Inside the Recent Surge in Biotech ETFs
Sep-13-16 04:10PM  Applied Genetics stock suffers record plunge to record low at MarketWatch
11:09AM  3 Reasons to Buy Teva Right Now
Sep-12-16 11:53AM  Biotech ETFs: Rallying Because Hillary Clinton Has Pneumonia? at Barrons.com
Sep-09-16 02:04PM  Here Are the Latest Analyst Recommendations for Biogen
Sep-04-16 01:00PM  How Financial Advisors Measure Capital Market Expectations (WFC, BLK) at Investopedia
Sep-02-16 04:04PM  Understanding Incytes Revenue Stream in 2Q16
10:49AM  Clinton's Proposal To Combat Drug Price Hikes
Aug-31-16 03:39PM  Biotech ETF Industry Outlook
11:53AM  Why Eylea Could Face Tough Competition in 2016
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.